Literature DB >> 15821758

The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.

Scott R Macfarlane1, Callum M Sloss, Pamela Cameron, Toru Kanke, Roderick C McKenzie, Robin Plevin.   

Abstract

1 In this study, we examined the role of Ca2+ in linking proteinase-activated receptor-2 (PAR2) to the nuclear factor kappa B (NFkappaB) pathway in a skin epithelial cell line NCTC2544 stably expressing PAR2 (clone G). 2 In clone G, PAR2-mediated NFkappaB luciferase reporter activity and NFkappaB DNA-binding activity was reduced by preincubation with BAPTA-AM but not BAPTA. Trypsin stimulation of inhibitory kappa B kinases, IKKalpha and IKKbeta, was also inhibited following pretreatment with BAPTA-AM. 3 BAPTA/AM also prevented PAR2-mediated IKKalpha activation in cultured primary human keratinocytes. 4 The effect of BAPTA-AM was also selective for the IKK/NFkappaB signalling axis; PAR2 coupling to ERK, or p38 MAP kinase was unaffected. 5 Pharmacological inhibition of the Ca2+-dependent regulatory protein calcineurin did not inhibit trypsin-stimulated IKK activity or NFkappaB-DNA binding; however, inhibition of Ca2+-dependent protein kinase C isoforms or InsP3 formation using GF109203X or the phospholipase C inhibitor U73122, respectively, reduced both IKK activity and NFkappaB-DNA binding. 6 Mutation of PAR2 within the C-terminal to produce a mutant receptor, which does not couple to Ca2+ signalling, but is able to activate ERK, abrogated NFkappaB-DNA binding and IKK activity stimulated by trypsin. 7 These results suggest a predominant role for the InsP3/Ca2+ axis in the regulation of IKK signalling and NFkappaB transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821758      PMCID: PMC1576156          DOI: 10.1038/sj.bjp.0706204

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes.

Authors:  S L Karvonen; T Korkiamäki; H Ylä-Outinen; M Nissinen; H Teerikangas; K Pummi; J Karvonen; J Peltonen
Journal:  J Invest Dermatol       Date:  2000-04       Impact factor: 8.551

2.  Elevated calcium in preneoplastic cells activates NF-kappa B and confers resistance to apoptosis.

Authors:  J Petranka; G Wright; R A Forbes; E Murphy
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

3.  PYK2 links G(q)alpha and G(13)alpha signaling to NF-kappa B activation.

Authors:  C S Shi; J H Kehrl
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

4.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 5.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

6.  The p38-MAPK/SAPK pathway is required for human keratinocyte migration on dermal collagen.

Authors:  W Li; C Nadelman; G Henry; J Fan; M Muellenhoff; E Medina; N S Gratch; M Chen; J Han; D Woodley
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

7.  Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes.

Authors:  T Kanke; S R Macfarlane; M J Seatter; E Davenport; A Paul; R C McKenzie; R Plevin
Journal:  J Biol Chem       Date:  2001-06-18       Impact factor: 5.157

8.  Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.

Authors:  Wael I Al-Daraji; Karen R Grant; Kerri Ryan; Angela Saxton; Nick J Reynolds
Journal:  J Invest Dermatol       Date:  2002-05       Impact factor: 8.551

9.  Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear.

Authors:  Junichi Kawagoe; Toshiaki Takizawa; Jiro Matsumoto; Masaki Tamiya; Stephen E Meek; Andrew J H Smith; Gary D Hunter; Robin Plevin; Naohiro Saito; Toru Kanke; Mikio Fujii; Yasushi Wada
Journal:  Jpn J Pharmacol       Date:  2002-01

10.  The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells.

Authors:  M Hayashi; Y Yamaji; Y Nakazato; T Saruta
Journal:  Hypertens Res       Date:  2000-09       Impact factor: 3.872

View more
  20 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 2.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

3.  Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes.

Authors:  Tatsuya Tsuda; Chika Ishikawa; Hiroe Konishi; Yoshiaki Hayashi; Noboru Nakagawa; Masato Matsuki; Hitoshi Mizutani; Kiyofumi Yamanishi
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

4.  The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages.

Authors:  S Hatziieremia; A I Gray; V A Ferro; A Paul; R Plevin
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

5.  PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.

Authors:  Jiahui Zhao; Admire Munanairi; Xian-Yu Liu; Jie Zhang; Linghan Hu; Meiqin Hu; Dingfang Bu; Lingling Liu; Zhiqiang Xie; Brian S Kim; Yong Yang; Zhou-Feng Chen
Journal:  J Invest Dermatol       Date:  2020-01-29       Impact factor: 8.551

6.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

Review 7.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  Phospholipase C, p38/MAPK, and NF-kappaB-mediated induction of MIP-3alpha/CCL20 by Porphyromonas gingivalis.

Authors:  Henrik Dommisch; Whasun O Chung; Søren Jepsen; Beth M Hacker; Beverly A Dale
Journal:  Innate Immun       Date:  2009-08-26       Impact factor: 2.680

9.  Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.

Authors:  T Kanke; M Kabeya; S Kubo; S Kondo; K Yasuoka; J Tagashira; H Ishiwata; M Saka; T Furuyama; T Nishiyama; T Doi; Y Hattori; A Kawabata; M R Cunningham; R Plevin
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

10.  Over-expression and localization of a host protein on the membrane of Cryptosporidium parvum infected epithelial cells.

Authors:  Yi-Lin Yang; Myrna G Serrano; Abhineet S Sheoran; Patricio A Manque; Gregory A Buck; Giovanni Widmer
Journal:  Mol Biochem Parasitol       Date:  2009-07-22       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.